The optimal timing of FDG-PET/CT in non-small cell lung cancer diagnosis and staging in an Australian centre
Abstract Background Clinical practice guidelines and re-imbursement schedules vary in the recommended timing of FDG-PET/CT in the diagnostic evaluation of suspected or confirmed lung cancer. The aim was to estimate the probability of requiring more than one invasive test to complete diagnosis and st...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-07-01
|
| Series: | BMC Pulmonary Medicine |
| Online Access: | https://doi.org/10.1186/s12890-021-01564-w |